Akbari A, Mobini GR, Agah S, Morvaridzadeh M, Omidi A, Potter E, Fazelian S, Ardehali SH, Daneshzad E, Dehghani S
P = .001) No significant effect on mental QoL or PANSS-6 scores Adverse Effects GI symptoms more frequent in semaglutide group Slightly higher hospitalization rates in semaglutide group No difference in the number of serious adverse events between groups Clinical Implications This study confirms that semaglutide is safe and highly effective for improving metabolic health in patients with schizophrenia receiving antipsychotics
According to published studies, cell therapy still faces significant challenges in terms oflong-term safety, treatment durability, cell preparation and cost, individual variability, and delivery methods [149]
The governor signed the bill on April 10
Contraindications Tirzepatide, whether compounded or brand-name, should not be used by individuals with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, severe gastroparesis or gastrointestinal disease, or during pregnancy
It is not an approved drug or dietary supplement ingredient and is generally categorized as a research-only compound